159 related articles for article (PubMed ID: 11383874)
1. 131I thyroid uptake in patients treated with 131I-Lipiodol for hepatocellular carcinoma.
Toubeau M; Touzery C; Berriolo-Riedinger A; Cochet A; Brunotte F; Bedenne L; Cercueil JP; Krause D
Eur J Nucl Med; 2001 May; 28(5):669-70. PubMed ID: 11383874
[No Abstract] [Full Text] [Related]
2. Iodine-131-Lipiodol for hepatocellular carcinoma: the benefits of targeting.
Novell JR; Hilson AJ
J Nucl Med; 1994 Aug; 35(8):1318-20. PubMed ID: 8046486
[No Abstract] [Full Text] [Related]
3. Intra-arterial radionuclide therapy for liver tumours: effect of selectivity of catheterization and 131I-Lipiodol delivery on tumour uptake and response.
Brans B; Bacher K; Vandevyver V; Vanlangenhove P; Smeets P; Thierens H; Dierckx RA; Defreyne L
Nucl Med Commun; 2003 Apr; 24(4):391-6. PubMed ID: 12673167
[TBL] [Abstract][Full Text] [Related]
4. Intraarterial HCC therapy with I-131-Lipiodol.
Risse JH; Grünwald F; Kersjes W; Strunk H; Caselmann WH; Palmedo H; Bender H; Biersack HJ
Cancer Biother Radiopharm; 2000 Feb; 15(1):65-70. PubMed ID: 10740654
[TBL] [Abstract][Full Text] [Related]
5. Following a trial that stopped early: what next for adjuvant hepatic intra-arterial iodine-131 lipiodol in resectable hepatocellular carcinoma?
Tan SB; Machin D; Cheung YB; Chung YF; Tai BC; Machin D
J Clin Oncol; 2002 Mar; 20(6):1709. PubMed ID: 11896125
[No Abstract] [Full Text] [Related]
6. Hepatocellular carcinoma; treatment with a radioiodinated fatty acid ester.
Yoo HS; Park CH; Suh JH; Lee JT; Kim DI; Kim BS; Choi HJ; Madsen MT
Yonsei Med J; 1988; 29(2):166-75. PubMed ID: 2851226
[No Abstract] [Full Text] [Related]
7. Preoperative treatment of hepatocellular carcinoma with intra-arterial injection of 131I-labelled lipiodol (Br J Surg 2003; 90: 1379-1383).
Rai R; Rai S
Br J Surg; 2004 Mar; 91(3):373; author reply 373. PubMed ID: 14991642
[No Abstract] [Full Text] [Related]
8. Guidelines for 131I-ethiodised oil (Lipiodol) therapy.
Eur J Nucl Med Mol Imaging; 2003 Mar; 30(3):BP20-2. PubMed ID: 12723561
[No Abstract] [Full Text] [Related]
9. Nodular hepatocellular carcinoma. Treatment with subsegmental intraarterial injection of iodine 131-labeled iodized oil.
Yoo HS; Lee JT; Kim KW; Kim BS; Choi HJ; Lee KS; Park CI; Park CY; Suh JH; Loh JJ
Cancer; 1991 Nov; 68(9):1878-84. PubMed ID: 1717129
[TBL] [Abstract][Full Text] [Related]
10. Selective internal radiation therapy with intra-arterial iodine-131-Lipiodol in inoperable hepatocellular carcinoma.
Leung WT; Lau WY; Ho S; Chan M; Leung N; Lin J; Ho KC; Metreweli C; Johnson PJ; Li AK
J Nucl Med; 1994 Aug; 35(8):1313-8. PubMed ID: 7519259
[TBL] [Abstract][Full Text] [Related]
11. Internal radiation therapy for hepatocellular carcinoma. Results of a French multicenter phase II trial of transarterial injection of iodine 131-labeled Lipiodol.
Raoul JI; Bretagne JF; Caucanas JP; Pariente EA; Boyer J; Paris JC; Michel H; Bourguet P; Victor G; Therain F
Cancer; 1992 Jan; 69(2):346-52. PubMed ID: 1309429
[TBL] [Abstract][Full Text] [Related]
12. [How I treat... An hepatocellular carcinoma: role of selective internal radiation therapy with intra-arterial iodine-131].
Werenne X
Rev Med Liege; 2007 Oct; 62(10):603-6. PubMed ID: 18069570
[TBL] [Abstract][Full Text] [Related]
13. Limitations of hyperselective intraarterial injections for the treatment of hepatocellular carcinoma.
Raoul JL; Bretagne JF; Bourguet P; Duvauferrier R
Invest Radiol; 1996 May; 31(5):305-7. PubMed ID: 8724131
[TBL] [Abstract][Full Text] [Related]
14. Epirubicin-Lipiodol chemotherapy versus 131iodine-Lipiodol radiotherapy in the treatment of unresectable hepatocellular carcinoma.
Bhattacharya S; Novell JR; Dusheiko GM; Hilson AJ; Dick R; Hobbs KE
Cancer; 1995 Dec; 76(11):2202-10. PubMed ID: 8635022
[TBL] [Abstract][Full Text] [Related]
15. The anti-tumoral activity of neoadjuvant intra-arterial 131I-lipiodol treatment for hepatocellular carcinoma: a pilot study.
Brans B; De Winter F; Defreyne L; Troisi R; Vanlangenhove P; Van Vlierberghe H; Lambert B; Praet M; de Hemptinne B; Dierckx RA
Cancer Biother Radiopharm; 2001 Aug; 16(4):333-8. PubMed ID: 11603004
[TBL] [Abstract][Full Text] [Related]
16. Treatment of hepatocellular carcinoma (HCC) with radiolabeled Lipiodol: a preliminary report.
Park CH; Suh JH; Yoo HS; Lee JT; Kim DI; Kim BS
Nucl Med Commun; 1987 Dec; 8(12):1075-87. PubMed ID: 2835716
[TBL] [Abstract][Full Text] [Related]
17. 18F-FDG-PET and histopathology in 131I-lipiodol treatment for primary liver cancer.
Risse JH; Pauleit D; Bender H; Rabe C; Fischer HP; Biersack HJ; Bucerius J
Cancer Biother Radiopharm; 2009 Aug; 24(4):445-52. PubMed ID: 19694579
[TBL] [Abstract][Full Text] [Related]
18. [Possibility of radiotherapy of hepatic cancer by transcatheter arterial embolization with radioactive Lipiodol].
Kobayashi H; Nakajo M; Shimabukuro K; Shirono K; Sakata H; Oyama T; Sonoda T; Shinohara S
Nihon Igaku Hoshasen Gakkai Zasshi; 1984 Jan; 44(1):96-8. PubMed ID: 6330667
[No Abstract] [Full Text] [Related]
19. Ablation of recurrent primary liver cancer using 131I-lipiodol.
Novell R; Hilson A; Hobbs K
Postgrad Med J; 1991 Apr; 67(786):393-5. PubMed ID: 1648718
[TBL] [Abstract][Full Text] [Related]
20. Preliminary experience in radionuclide therapy of hepatocellular carcinoma using hepatic intra-arterial radio-conjugates.
Keng GH; Sundram FX; Yu SW; Somanesan S; Premaraj J; Oon CJ; Kwok R; Htoo MM
Ann Acad Med Singap; 2002 May; 31(3):382-6. PubMed ID: 12061301
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
